Delivery Order SPE2DB22D2006-SPE2DB25FV7JX
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
The federal contract award SPE2DB22D3016|SPE2DB25FAHA4, valued at $23,905.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,770,435 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of December 20, 2024. AmerisourceBergen holds a...
This federal contract award, valued at $4,451.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,263,481 units of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and is scheduled for completion by October 30, 2024. This award is a delivery order under a larger Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT2G7, is a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,749,659 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting.
The contract has a ceiling value of $3,110.36 and a completion date of October 13, 2022. It is a Firm Fixed Price contract,...
This federal contract award, valued at $2,712.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,510,655 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNR59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,584,339 units of the drug Ondansetron HCL 4 mg Tablet. The contract has a ceiling value of $22,425.02 and a completion date of December 3, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen, the prime contractor, has a significant...
This federal contract award, valued at $44,524.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,276 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting.
The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 10, 2024. This award is not associated with...
This federal contract award, valued at $1,170.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,488,955 units of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a performance period ending on November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $11,863.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,986,378 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting.
The contract, which has a firm fixed price, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for 4,565,644 units of the pharmaceutical product Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The fixed-price contract has a ceiling value of $12,567.14 and a completion date of September 3, 2024. As this contract award did not utilize any...